ERBB2 and neoplasm: Within the n = 49 breast cancer cases, no statistical differences in the expression levels of both miRs were found regarding tumour stage, nodal status, hormonal receptor status, HER2 status or triple negative breast cancer (TNBC) status (data not shown).